Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies
暂无分享,去创建一个
K. Waki | T. Kadowaki | P. Terasaki | Y. Sugawara | N. Kokudo | M. Nozawa | Koki Takahashi | J. Kaneko | K. Mizuta | M. Hirata | M. Ozawa | M. Taniguchi
[1] A. Demetris. Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance , 2012 .
[2] C. Bellamy. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] G. Klintmalm,et al. Bortezomib for Acute Antibody‐Mediated Rejection in Liver Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] W. Suki,et al. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. , 2012, Kidney international.
[5] G. Klintmalm,et al. Donor‐specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] C. Roufosse,et al. De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy , 2012, Transplantation.
[7] P. Rosenthal,et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. , 2012, JAMA.
[8] Y. Li,et al. Factors affecting operational tolerance after pediatric living‐donor liver transplantation: impact of early post‐transplant events and HLA match * , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[9] G. Klintmalm,et al. High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] S. Alexander,et al. Approaching the Promise of Operational Tolerance in Clinical Transplantation , 2011, Transplantation.
[11] H. Regele. Non-HLA antibodies in kidney allograft rejection: convincing concept in need of further evidence. , 2011, Kidney international.
[12] J. Pirsch,et al. The Significance of Donor‐Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] N. Banner,et al. De Novo Donor HLA‐Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] K. Waki,et al. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. , 2011, Clinical transplants.
[15] G. Mazariegos,et al. Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies. , 2010, Human immunology.
[16] P. Terasaki,et al. Human leukocyte antigen crossmatch testing is important for liver retransplantation , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] G. Pantaleo,et al. Prevalence of anti‐HLA antibodies after liver transplantation , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[18] S. Soker,et al. Operational tolerance after liver transplantation. , 2009, Journal of hepatology.
[19] M. Makuuchi,et al. Positive Lymphocytotoxic Crossmatch Does Not Adversely Affect Survival in Living Donor Liver Transplantation , 2009, Digestive Surgery.
[20] S. Knechtle,et al. Unique aspects of rejection and tolerance in liver transplantation. , 2009, Seminars in liver disease.
[21] A. Demetris,et al. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[22] J. Vacanti,et al. The Need for Tolerance in Pediatric Organ Transplantation , 2008, Pediatrics.
[23] E. Paz-Artal,et al. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] G. Mazariegos,et al. High PD-L1/CD86 Ratio on Plasmacytoid Dendritic Cells Correlates With Elevated T-Regulatory Cells in Liver Transplant Tolerance , 2008, Transplantation.
[25] Y. Li,et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. , 2007, Transplant immunology.
[26] P. Terasaki,et al. Development of Nondonor‐Specific HLA‐DR Antibodies in Allograft Recipients Is Associated with Shared Epitopes with Mismatched Donor DR Antigens , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] John D Lambris,et al. Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes? , 2006, Molecular immunology.
[28] P. Terasaki,et al. Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] P. Terasaki,et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. , 2005, Journal of the American Society of Nephrology : JASN.
[30] A. Minguela,et al. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. , 2005, Transplant immunology.
[31] G. Opelz. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies , 2005, The Lancet.
[32] Yoshimasa Tanaka,et al. Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] A. Friedl,et al. Correlation Between Human Leukocyte Antigen Antibody Production and Serum Creatinine in Patients Receiving Sirolimus Monotherapy after Campath-1H Induction , 2004, Transplantation.
[34] G. McCaughan,et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. , 2004, The Journal of clinical investigation.
[35] J. Jamart,et al. Impact of Surgical and Immunological Parameters in Pediatric Liver Transplantation: A Multivariate Analysis in 500 Consecutive Recipients of Primary Grafts , 2004, Annals of surgery.
[36] K. Savik,et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. , 2002, Transplantation.
[37] R. Howard,et al. Susceptibility of Liver Allografts to High or Low Concentrations of Preformed Antibodies as Measured by Flow Cytometry , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] S. Knechtle. Knowledge about transplantation tolerance gained in primates. , 2000, Current opinion in immunology.
[39] S. Uemoto,et al. Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. , 1999, Transplantation.
[40] A. Sheil,et al. Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. , 1998, Transplantation.
[41] B. Portmann,et al. Defining the outcome of immunosuppression withdrawal after liver transplantation , 1998, Hepatology.
[42] G. Szot,et al. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. , 1997, Journal of immunology.
[43] T. Starzl,et al. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. , 1997, Transplantation.
[44] Wei Li,et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. , 1997, Journal of immunology.
[45] T. Starzl,et al. Weaning of immunosuppression in liver transplant recipients. , 1997, Transplantation.
[46] A. Sheil,et al. Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. , 1996, Transplantation.
[47] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[48] A. Sheil,et al. DELETION OF SPONTANEOUS RAT LIVER ALLOGRAFT ACCEPTANCE BY DONOR IRRADIATION , 1995, Transplantation.
[49] R. Calne,et al. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats , 1995, Nature Medicine.
[50] S. Ménoret,et al. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01. , 1995, Transplantation.
[51] D. Sachs,et al. Tolerance to Primarily Vascularized Allografts in Miniature Swine , 1993, Immunological reviews.
[52] T. Starzl,et al. THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2 , 1992, Transplantation.
[53] T. Sablinski,et al. CD4 monoclonal antibodies in organ transplantation--a review of progress. , 1991, Transplantation.
[54] N. Perico,et al. Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation , 1991, The Lancet.
[55] N. Kamada,et al. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. , 1985, Immunology.